CNBX Pharmaceuticals Inc. (OTCQB: CNBX) has acquired a controlling interest in TaGeza Biopharmaceuticals Ltd. The TaGeza research team remains committed to the company, and co-founder professor Benjamin Dekel (MD, PhD) will continue to serve as the company's chief scient
AFC Gamma, Inc. (NASDAQ: AFCG) released its results for the third quarter of 2022, revealing net income of $11.5 million in Q3 2022, or $0.57 per basic weighted average share of common stock, representing a 45% increase to net income from Q3 2021.
MariMed, Inc. (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, recently announced its financial results for the third quarter that ended September 30, 2022.